Komori
Daiken Medical (7775) · FactAdvanced

Calculation of Scope-Based GHG Emissions

First written in FY2023. 3 of 4 entries say "Advanced", first in FY2024. Latest entry: FY2026.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023AdvancedFY2024 – FY20262023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Calculation and disclosure of Scope 1–3 emissionsA theme 27 companies write about · 0 as a headwind · 14 as a tailwind

11 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 27 companies compared. The sentences above are computed from all 27.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Scope１ 207 ｔ-CO2 Scope２ 1,011 ｔ-CO2 Scope３ 21,971 ｔ-CO2 総排出量 23,189 ｔ-CO2」

    2024年度のGHG排出量を追加開示した。Scope1は207t-CO2、Scope2は1,011t-CO2、Scope3は21,971t-CO2、総排出量は23,189t-CO2で、Scope3は前年度比約0.5％減少した。
  2. FY2025AdvancedAnnual report

    「2023年度数値に係る前年度比較の結果といたしましては、Scope１はほぼ横ばい、Scope２は電力係数の増加に伴い増加、Scope３は同年度中における各種取り組みによって６％程度削減することができました。」

    2023年度の排出量としてScope1 195t-CO2、Scope2 1,069t-CO2、Scope3 22,091t-CO2、総排出量23,354t-CO2を開示した。Scope3は前年度比で6％程度削減された。
  3. FY2024AdvancedAnnual report

    「Scope１ 207.498 ｔ-CO2eq Scope２ 786.388 ｔ-CO2eq Scope３ 23,497.549 ｔ-CO2eq 総排出量 24,491.435 ｔ-CO2eq」

    2022年度のGHG排出量を追加開示し、Scope1は207.498t-CO2eq、Scope2は786.388t-CO2eq、Scope3は23,497.549t-CO2eq、総排出量は24,491.435t-CO2eqとなった。
  4. FY2023First statedAnnual report

    「Scope１ 203.23　ｔ-CO2eq Scope２ 728.46　ｔ-CO2eq Scope３ 16,623.14　ｔ-CO2eq Scope３（上流） 16,597.93　ｔ-CO2eq Scope３（下流） 25.20　ｔ-CO2eq 総排出量 17,554.83　ｔ-CO2eq」

    2021年度のGHG排出量を初めて開示した。スコープ1は203.23t-CO2eq、スコープ2は728.46t-CO2eq、スコープ3は16,623.14t-CO2eq、総排出量は17,554.83t-CO2eqである。スコープ3が全体の95％を占めると説明している。
Moved together

"Changes in Executive Positions, Including the Representative Director and President" moved the same way as this thread, in the same document, in 3 of its 4 moves.

333332★123456
  1. ★This thread
  2. 1Changes in Executive Positions, Including the Representative Director and President3×
  3. 2Revenue Growth Driven by Suction Devices and Cue-in-Pot3×
  4. 3Increase in Net Assets from Profit Recognition and Dividends3×
  5. 4Recovery in Infusion-Device-Related Sales3×
  6. 5Increase in the Equity Ratio3×
  7. 6Pressure on Operating Profit from Higher Personnel and R&D Expenses2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Daiken Medical's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Calculation of Scope-Based GHG Emissions | DAIKEN MEDICAL CO.,LTD. (7775) | Komori